4//SEC Filing
BENSON REED L 4
Accession 0001562180-21-003687
CIK 0001692415other
Filed
May 20, 8:00 PM ET
Accepted
May 21, 12:43 PM ET
Size
19.1 KB
Accession
0001562180-21-003687
Insider Transaction Report
Form 4
BENSON REED L
Chief Financial Officer
Transactions
- Sale
Common Stock
2021-05-19$8.54/sh−10,920$93,232→ 97,414 total - Sale
Common Stock
2021-05-19$8.52/sh−97,413$830,387→ 1 total - Sale
Common Stock
2021-05-19$8.53/sh−1$9→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-05-19−1→ 13,891 totalExercise: $1.10Exp: 2029-09-02→ Common Stock (1 underlying) - Exercise/Conversion
Common Stock
2021-05-19$1.10/sh+1$1→ 1 total - Exercise/Conversion
Common Stock
2021-05-19$2.63/sh+10,920$28,720→ 10,921 total - Exercise/Conversion
Common Stock
2021-05-19$2.63/sh+97,413$256,196→ 108,334 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-05-19−97,413→ 0 totalExercise: $2.63Exp: 2028-09-20→ Common Stock (97,413 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2021-05-19−10,920→ 0 totalExercise: $2.63Exp: 2028-09-20→ Common Stock (10,920 underlying)
Footnotes (4)
- [F1]This transaction was executed in multiple trades at prices ranging from $8.52 USD to $8.55 USD; the price reported above reflects the weighted average sale price.
- [F2]This transaction was executed in multiple trades at prices ranging from $8.47 USD to $8.64 USD; the price reported above reflects the weighted average sale price.
- [F3]1/3 on day of grant; 1/3 after year 1, 1/3 after year 2 beginning on 21-Sep-2018
- [F4]1/3 on day of grant; 1/3 after year 1, 1/3 after year 2 beginning on 03-Sep-2019
Documents
Issuer
Co-Diagnostics, Inc.
CIK 0001692415
Entity typeother
Related Parties
1- filerCIK 0001162886
Filing Metadata
- Form type
- 4
- Filed
- May 20, 8:00 PM ET
- Accepted
- May 21, 12:43 PM ET
- Size
- 19.1 KB